Skip to main content
. 2021 May 28;100(21):e25808. doi: 10.1097/MD.0000000000025808

Figure 1.

Figure 1

Comparison of miR-96-5p expression levels in placenta. (A) miR-96-5p expression in placenta samples from patients with gestational diabetes mellitus (GDM) and control participants. (B) Correlation between the miR-96-5p expression in placenta samples and fasting blood glucose levels of patients with GDM. ∗∗∗P < .001.